Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1300-1308

  Luangtongkum, Taradon ^a,b   Shen, Zhangqi ^a   Seng, Virginia W ^a   Sahin, Orhan ^a   Jeon, Byeonghwa ^a,d   Liu, Peng ^c   Zhang, Qijing ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

^d UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MACROLIDE; RIBOSOME RNA;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM MUTANT; CAMPYLOBACTER JEJUNI; CHICKEN; COMINGLING EXPERIMENT; DISEASE CARRIER; EXPERIMENTAL DESIGN; MUTATION; NATURAL HOST; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHICKENS; COLONY COUNT, MICROBIAL; DISEASE RESERVOIRS; ERYTHROMYCIN; GENETIC FITNESS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; MUTATION; POULTRY DISEASES; RNA, RIBOSOMAL, 23S;

EID: 84863164991     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05516-11     Document Type: Article

References (45)

1. Aarestrup FM, McDermott PF, Wegener HC. 2008. Transmission of antibiotic resistance from food animals to humans, p 645-665. In Nachamkin I, Szymanski CM, Blaser MJ (ed), Campylobacter, 3rd ed. ASM Press, Washington, DC.
2. Allos BM. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32:1201-1206. (Pubitemid 32381123)
3. Almofti YA, Dai M, Sun Y, Haihong H, Yuan Z. 2011. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Microb. Pathog. 50:336-342.
4. Altekruse SF, Tollefson LK. 2003. Human campylobacteriosis: a challenge for the veterinary profession. J. Am. Vet. Med. Assoc. 223:445-452. (Pubitemid 36988712)
5. Andersson DI. 2003. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6:452-456. (Pubitemid 37345409)
6. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8:260-271.
7. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493. (Pubitemid 29477174)
8. Binet R, Bowlin AK, Maurelli AT, Rank RG. 2010. Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicrob. Agents Chemother. 54:1094-1101.
9. Bjorkholm B, et al. 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 98:14607-14612. (Pubitemid 33121439)
10. Bjorkman J, Hughes D, Andersson DI. 1998. Virulence of antibiotic-resistant Salmonella Typhimurium. Proc. Natl. Acad. Sci. U. S. A. 95: 3949-3953. (Pubitemid 28173234)
11. Bjorkman J, Nagaev I, Berg OG, Hughes D, Andersson DI. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482. (Pubitemid 30127140)
12. Blaser MJ, Engberg J. 2008. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections, p 99-121. In Nachamkin I, Szymanski CM, Blaser MJ (ed), Campylobacter, 3rd ed. ASM Press, Washington, DC.
13. Cagliero C, Mouline C, Cloeckaert A, Payot S. 2006. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 50:3893-3896. (Pubitemid 44684910)
14. Caldwell DB, Wang Y, Lin J. 2008. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52:3947-3954.
15. Champney WS, Burdine R. 1998. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. Microb. Drug Resist. 4:169-174. (Pubitemid 28500714)
16. Clinical Laboratory Standards Institute. 2008. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard M31-A3, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
17. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34. (Pubitemid 32173330)
18. Fernando U, Biswas D, Allan B, Willson P, Potter AA. 2007. Influence of Campylobacter jejuni fliA, rpoN, and flgK genes on colonization of the chicken gut. Int. J. Food Microbiol. 118:194-200. (Pubitemid 47361399)
19. Gibreel A, et al. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759. (Pubitemid 40917588)
20. Gibreel A, Taylor DE. 2006. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 58:243-255. (Pubitemid 44294933)
21. Giguere S. 2006. Macrolides, azalides, and ketolides, p 191-205. In Giguere S et al. (ed), Antimicrobial therapy in veterinary medicine, 4th ed. Blackwell Publishing Professional, Ames, IA.
22. Gilbert JM, White DG, McDermott PF. 2007. The US national antimicrobial resistance monitoring system. Future Microbiol. 2:493-500. (Pubitemid 47591322)
23. Guerry P. 2007. Campylobacter flagella: not just for motility. Trends Microbiol. 15:456-461. (Pubitemid 350026355)
24. Guo B, et al. 2008. CmeR functions as a pleiotropic regulator and is required for optimal colonization of Campylobacter jejuni in vivo. J. Bacteriol. 190:1879-1890. (Pubitemid 351355311)
25. Han F, Pu S, Wang F, Meng J, Ge B. 2009. Fitness cost of macrolide resistance in Campylobacter jejuni. Int. J. Antimicrob. Agents 34:462-466.
26. Han J, Sahin O, Barton YW, Zhang Q. 2008. Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni. PLoS Pathog. 4:e1000083.
27. Hao H, et al. 2009. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb. Drug Resist. 15:239-244.
28. Hendrixson DR. 2008. Regulation of flagellar gene expression and assembly, p 545-558. In Nachamkin I, Szymanski CM, Blaser MJ (ed), Campylobacter, 3rd ed. ASM Press, Washington, DC.
29. Jensen LB, Aarestrup FM. 2001. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrob. Agents Chemother. 45: 371-372. (Pubitemid 32039152)
30. Johnsen PJ, Simonsen GS, Olsvik O, Midtvedt T, Sundsfjord A. 2002. Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. Microb. Drug Resist. 8:161-170.
31. Kanai K, Shibayama K, Suzuki S, Wachino J, Arakawa Y. 2004. Growth competition of macrolide-resistant and -susceptible Helicobacter pylori strains. Microbiol. Immunol. 48:977-980. (Pubitemid 40040706)
32. Ladely SR, et al. 2007. Development of macrolide-resistant Campylobacter in broilers administered subtherapeutic or therapeutic concentrations of tylosin. J. Food Prot. 70:1945-1951. (Pubitemid 47237419)
33. Levin BR, Perrot V, Walker N. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985-997. (Pubitemid 30140690)
34. Lin J, et al. 2007. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob. Agents Chemother. 51:1678 -1686.
35. Luangtongkum T, et al. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4:189-200.
36. Luangtongkum T, et al. 2006. Effect of conventional and organic production practices on the prevalence and antimicrobial resistance of Campylobacter spp. in poultry. Appl. Environ. Microbiol. 72:3600-3607. (Pubitemid 43728016)
37. Luo N, et al. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U. S. A. 102:541-546. (Pubitemid 40282701)
38. Michon A, et al. 2011. Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure. PLoS One 6:e24552.
39. Nachamkin I, Yang XH, Stern NJ. 1993. Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Appl. Environ. Microbiol. 59:1269-1273. (Pubitemid 23141128)
40. Nagaev I, Bjorkman J, Andersson DI, Hughes D. 2001. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40:433-439. (Pubitemid 32391637)
41. Payot S, et al. 2006. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect. 8:1967-1971. (Pubitemid 44144560)
42. Pedersen K, Wedderkopp A. 2003. Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level. J. Appl. Microbiol. 94:111-119. (Pubitemid 36051312)
43. Price LB, Lackey LG, Vailes R, Silbergeld E. 2007. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ. Health Perspect. 115:1035-1039. (Pubitemid 47317068)
44. Sander P, et al. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-1211. (Pubitemid 34415292)
45. Wang Y, Taylor DE. 1990. Natural transformation in Campylobacter species. J. Bacteriol. 172:949-955. (Pubitemid 20070406)